Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older

NCT01453088 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

63

Enrollment

OTHER

Sponsor class

Stopped Lack of Accrual

Conditions

Multiple Myeloma

Interventions

DRUG: Melphalan
DRUG: Bortezomib

Sponsor

Hackensack Meridian Health